Cargando…

Defining Zoledronate’s Duration of Action and Optimal Dosing Interval for an Effective Therapy

Detalles Bibliográficos
Autor principal: Silverman, Stuart L.
Formato: Texto
Lenguaje:English
Publicado: Current Science Inc. 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026771/
https://www.ncbi.nlm.nih.gov/pubmed/21161452
http://dx.doi.org/10.1007/s11914-010-0044-x
_version_ 1782197079408377856
author Silverman, Stuart L.
author_facet Silverman, Stuart L.
author_sort Silverman, Stuart L.
collection PubMed
description
format Text
id pubmed-3026771
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Current Science Inc.
record_format MEDLINE/PubMed
spelling pubmed-30267712011-02-22 Defining Zoledronate’s Duration of Action and Optimal Dosing Interval for an Effective Therapy Silverman, Stuart L. Curr Osteoporos Rep Clinical Trial Report Current Science Inc. 2010-12-16 2011 /pmc/articles/PMC3026771/ /pubmed/21161452 http://dx.doi.org/10.1007/s11914-010-0044-x Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Clinical Trial Report
Silverman, Stuart L.
Defining Zoledronate’s Duration of Action and Optimal Dosing Interval for an Effective Therapy
title Defining Zoledronate’s Duration of Action and Optimal Dosing Interval for an Effective Therapy
title_full Defining Zoledronate’s Duration of Action and Optimal Dosing Interval for an Effective Therapy
title_fullStr Defining Zoledronate’s Duration of Action and Optimal Dosing Interval for an Effective Therapy
title_full_unstemmed Defining Zoledronate’s Duration of Action and Optimal Dosing Interval for an Effective Therapy
title_short Defining Zoledronate’s Duration of Action and Optimal Dosing Interval for an Effective Therapy
title_sort defining zoledronate’s duration of action and optimal dosing interval for an effective therapy
topic Clinical Trial Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3026771/
https://www.ncbi.nlm.nih.gov/pubmed/21161452
http://dx.doi.org/10.1007/s11914-010-0044-x
work_keys_str_mv AT silvermanstuartl definingzoledronatesdurationofactionandoptimaldosingintervalforaneffectivetherapy